Amyotrophic lateral sclerosis: new genes, new models, and new mechanisms

Research aimed at understanding amyotrophic lateral sclerosis (ALS) has seen exceptional growth in the past few years. New genes, new models, and new mechanisms have not only improved our understanding, but also contributed to the increasing complexity of ALS pathogenesis. The focus of this piece is to highlight some of the more notable developments in the field and to encourage a re-appreciation for the superoxide dismutase 1 (SOD1) mouse models.

[1]  J. Jia,et al.  Nuclear localization sequence of FUS and induction of stress granules by ALS mutants , 2011, Neurobiology of Aging.

[2]  H. Kawakami,et al.  Screening for OPTN mutations in amyotrophic lateral sclerosis in a mainly Caucasian population , 2011, Neurobiology of Aging.

[3]  Sameer B. Shah,et al.  Misfolded SOD1 Associated with Motor Neuron Mitochondria Alters Mitochondrial Shape and Distribution Prior to Clinical Onset , 2011, PloS one.

[4]  E. Rogaeva,et al.  RNA targets of TDP-43 identified by UV-CLIP are deregulated in ALS , 2011, Molecular and Cellular Neuroscience.

[5]  V. Meininger,et al.  Association of long ATXN2 CAG repeat sizes with increased risk of amyotrophic lateral sclerosis. , 2011, Archives of neurology.

[6]  G. Comi,et al.  Novel optineurin mutations in patients with familial and sporadic amyotrophic lateral sclerosis , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[7]  B. Miller,et al.  Ataxin-2 repeat-length variation and neurodegeneration. , 2011, Human molecular genetics.

[8]  M. Cudkowicz,et al.  Emerging targets and treatments in amyotrophic lateral sclerosis , 2011, The Lancet Neurology.

[9]  P. Andersen,et al.  Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients. , 2011, Human molecular genetics.

[10]  Robert H. Brown,et al.  Mutational analysis reveals the FUS homolog TAF15 as a candidate gene for familial amyotrophic lateral sclerosis , 2011, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[11]  G. Rouleau,et al.  TAR DNA-binding protein 43 (TDP-43) regulates stress granule dynamics via differential regulation of G3BP and TIA-1. , 2011, Human molecular genetics.

[12]  J. Ule,et al.  Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. , 2011, Nature neuroscience.

[13]  John Q. Trojanowski,et al.  PolyQ Repeat Expansions in ATXN2 Associated with ALS Are CAA Interrupted Repeats , 2011, PloS one.

[14]  V. Meininger,et al.  Screening of OPTN in French familial amyotrophic lateral sclerosis , 2011, Neurobiology of Aging.

[15]  Gene W. Yeo,et al.  Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43 , 2011, Nature Neuroscience.

[16]  C. B. Kunst,et al.  Effect of genetic background on phenotype variability in transgenic mouse models of amyotrophic lateral sclerosis: A window of opportunity in the search for genetic modifiers , 2011, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[17]  Patrizia Sola,et al.  Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS , 2011, Neuron.

[18]  G. Comi,et al.  TARDBP mutations in frontotemporal lobar degeneration: frequency, clinical features, and disease course. , 2010, Rejuvenation research.

[19]  J. Yates,et al.  ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import , 2010, Proceedings of the National Academy of Sciences.

[20]  Frederick P. Roth,et al.  Identification of Neuronal RNA Targets of TDP-43-containing Ribonucleoprotein Complexes , 2010, The Journal of Biological Chemistry.

[21]  Robert H. Brown,et al.  Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. , 2010, Human molecular genetics.

[22]  L. Petrucelli,et al.  Tar DNA Binding Protein-43 (TDP-43) Associates with Stress Granules: Analysis of Cultured Cells and Pathological Brain Tissue , 2010, PloS one.

[23]  Jeffery N Agar,et al.  Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS , 2010, Nature Neuroscience.

[24]  V. Shoshan-Barmatz,et al.  Misfolded Mutant SOD1 Directly Inhibits VDAC1 Conductance in a Mouse Model of Inherited ALS , 2010, Neuron.

[25]  John Q. Trojanowski,et al.  Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS , 2010, Nature.

[26]  I. Mackenzie,et al.  ALS‐associated fused in sarcoma (FUS) mutations disrupt Transportin‐mediated nuclear import , 2010, The EMBO journal.

[27]  Johan Jacobsson,et al.  Novel Antibodies Reveal Inclusions Containing Non-Native SOD1 in Sporadic ALS Patients , 2010, PloS one.

[28]  Janel O. Johnson,et al.  Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients , 2010, Proceedings of the National Academy of Sciences.

[29]  J. Julien,et al.  Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS , 2010, Journal of neurochemistry.

[30]  Takeo Kato,et al.  Mutations of optineurin in amyotrophic lateral sclerosis , 2010, Nature.

[31]  R. Chitta,et al.  Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. , 2010, Journal of proteome research.

[32]  D. Cleveland,et al.  Non–cell autonomous toxicity in neurodegenerative disorders: ALS and beyond , 2009, The Journal of cell biology.

[33]  E. Buratti,et al.  TDP‐43 is recruited to stress granules in conditions of oxidative insult , 2009, Journal of neurochemistry.

[34]  M. Luca,et al.  Mutation within TARDBP leads to Frontotemporal Dementia without motor neuron disease , 2009, Human mutation.

[35]  G. Rouleau,et al.  Genetics of motor neuron disorders: new insights into pathogenic mechanisms , 2009, Nature Reviews Genetics.

[36]  Claire L. Simpson,et al.  Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis , 2009, Proceedings of the National Academy of Sciences.

[37]  D. Cleveland,et al.  Rethinking ALS: The FUS about TDP-43 , 2009, Cell.

[38]  M. Strong,et al.  Divergent patterns of cytosolic TDP-43 and neuronal progranulin expression following axotomy: Implications for TDP-43 in the physiological response to neuronal injury , 2009, Brain Research.

[39]  R. Ophoff,et al.  Analysis of genome-wide copy number variation in Irish and Dutch ALS populations. , 2008, Human molecular genetics.

[40]  D. Cleveland,et al.  Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria , 2008, Proceedings of the National Academy of Sciences.

[41]  I. Bertini,et al.  SOD1 and Amyotrophic Lateral Sclerosis: Mutations and Oligomerization , 2008, PloS one.

[42]  J. Julien,et al.  Wild‐type superoxide dismutase acquires binding and toxic properties of ALS‐linked mutant forms through oxidation , 2007, Journal of neurochemistry.

[43]  A. Chakrabartty,et al.  An immunological epitope selective for pathological monomer-misfolded SOD1 in ALS , 2007, Nature Medicine.

[44]  Bruce L. Miller,et al.  Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.

[45]  D. Cleveland,et al.  ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors , 2006, Neuron.

[46]  Charles D. Smith,et al.  Novel Ubiquitin Neuropathology in Frontotemporal Dementia With Valosin-Containing Protein Gene Mutations , 2006, Journal of neuropathology and experimental neurology.

[47]  Ole Gredal,et al.  Toxicity of Familial ALS-Linked SOD1 Mutants from Selective Recruitment to Spinal Mitochondria , 2004, Neuron.

[48]  Robert H. Brown,et al.  Amyotrophic Lateral Sclerosis-Associated SOD1 Mutant Proteins Bind and Aggregate with Bcl-2 in Spinal Cord Mitochondria , 2004, Neuron.

[49]  A. Pestronk,et al.  Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein , 2004, Nature Genetics.

[50]  D. Neary,et al.  Cognitive change in motor neurone disease/amyotrophic lateral sclerosis (MND/ALS) , 2000, Journal of the Neurological Sciences.

[51]  P. Leigh,et al.  Dose-ranging study of riluzole in amyotrophic lateral sclerosis , 1996, The Lancet.

[52]  J. Weissenbach,et al.  Identification and characterization of a spinal muscular atrophy-determining gene , 1995, Cell.

[53]  V. Meininger,et al.  A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. , 1994, The New England journal of medicine.

[54]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[55]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[56]  P. Leigh,et al.  Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. , 1996, Lancet.